Included in this quarter's GAAP income is $36 million of share-based compensation expense. Excluding this item and $10 million of other net adjustments, Agilent reported fourth quarter adjusted net income of $206 million, or $0.53 per share. On a comparable basis, the company earned $190 million, or $0.45 per share, one year ago. (1)
"Agilent had a good fiscal fourth quarter, especially considering the continued divergent trends of our markets," said Bill Sullivan, Agilent president and chief executive officer. "Bio-analytical markets were strong in both Chemical Analysis and Life Sciences, and across all geographies. Electronic measurement markets were very mixed, with strength in aerospace / defense and wireless R&D, a flat profile for wireless handset and electronic manufacturing test, and weakness in computer and semiconductor markets."
Total fourth quarter revenues were up 9 percent from last year to $1.45 billion. Adjusted net income per share, at $0.53, was 18 percent above last year's results and near the top of the $0.50 - $0.54 guidance range.
Sullivan noted that the Bio-Analytical segment grew at a double-digit pace for the sixth consecutive quarter, and that the segment operating margin was at a record level. "We are seeing sustained strength in our new Liquid Chromatograph, Mass Spectroscopy and Gas Chromatograph platforms, and Stratagene integration activities continue to go well. Last week, we announced the acquisition of Velocity11, adding lab automation to our expanding workflow solutions."
"While the Electronic Measurement segment was flat overall, we saw good growth in those areas where we have invested in specific growth initiatives, such as aerospace / defense and wireless R&D," said Sullivan.
Fourth quarter Return on Invested Capital(2) reached a new high of 30 percent, a point better than last year's strong performance. Both Receivables Days-Sales-Outstanding and Inventory Days-On-Hand reached new historic lows. Cash generated from operating activities was $398 million in the fourth quarter. During the period, the company repurchased $631 million of its common stock, completing its $2 billion buyback program.
Full fiscal 2007 revenues grew 9 percent to $5.4 billion. Adjusted net income per share rose 22 percent to $1.82. Return on Invested Capital reached 27 percent, and cash generated from operating activities during fiscal 2007 was $969 million.
Said Sullivan, "Today, Agilent's Board of Directors authorized a new program to repurchase up to $2 billion of Agilent's common shares, reflecting its confidence in Agilent's ability to create superior shareholder value, leveraging our operating model through higher sustainable growth."
Looking ahead, Sullivan said the company was comfortable with the range of analyst estimates for FY2008 revenues and adjusted net income per share. (3) For the fiscal first quarter of 2008, revenues are expected to be in the range of $1.35 billion to $1.40 billion, up 5 percent to 9 percent from last year.
Comparisons of this year's first quarter adjusted net income will be affected by a change in the timing of Agilent's annual compensation awards program, and by a shift toward more variable compensation. Compared to last year, about $32 million more compensation-related expense will be recognized in Q1FY08. That $0.06 per share cost increase will be offset by a $0.04 reduction in Q2 expense, and by $0.01 reductions in FY08's Q3 and Q4. Reflecting this changed pattern of compensation expense, first quarter adjusted net income is expected to be in the range of $0.38 to $0.43 per share, 15 percent to 30 percent above last year's comparable earnings. (4)
Segment Results
-------------------------------------------
Bio-Analytical Measurement
($ millions except where noted)
Q4:F07 Q4:F06 Q3:F07
-------- -------- --------
Orders 571 493 498
Revenues 558 450 500
Gross Margin, % 55% 55% 54%
Income from Operations 120 91 92
Segment Assets 1,307 1,003 1,304
Return On Invested Capital(2), % 33% 36% 29%
Bio-Analytical Measurement orders were up 16 percent during the fourth quarter from one year ago, and up 11 percent excluding the impact of the acquisition of Stratagene. Revenues of $558 million were up 24 percent from last year, and up 19 percent excluding Stratagene. Revenues were strong in both Life Sciences and Chemical Analysis end markets and were well balanced geographically, with all regions up over 20 percent from one year ago.
Life Sciences revenue was up 30 percent from one year ago, and up 17 percent excluding Stratagene. Sustained strength in the pharmaceutical and biotech markets fueled growth of our 1200 Series liquid chromatography, mass spectrometry and LC/MS platforms as well as demand for microarray applications. Participation in the academic & government market more than doubled over the year, and rose 25 percent organically. Chemical Analysis revenues of $322 million were up 20 percent from last year, driven by continued strength in petrochemical, food safety and environmental end markets. Strong market acceptance of the new 7890 gas chromatograph and continued strength of the LC/MS portfolio drove demand in chemical analysis markets.
Segment income from operations of $120 million was $29 million above last year on a $108 million increase in revenues. Operating margins improved one point to 21 percent. Segment Return On Invested Capital(2) dropped 3 points to 33 percent because of a 4-point reduction due to the addition of Stratagene.
Electronic Measurement
-------------------------------------------
($ millions except where noted)
Q4:F07 Q4:F06 Q3:F07
-------- -------- --------
Orders 912 904 810
Revenues 888 878 874
Gross Margin, % 57% 57% 58%
Income from Operations 133 137 133
Segment Assets 2,025 2,075 2,042
Return On Invested Capital(2), % 27% 27% 26%
Fourth quarter Electronic Measurement orders of $912 million were 1 percent above last year. Revenues of $888 million were also up 1 percent, with Americas up 2 percent and Europe up 12 percent, while revenues from Asia were down 4 percent. General Purpose Test revenues were 1 percent ahead of last year, with strength in aerospace / defense offset by weakness in computing and semiconductors. Communications Test revenues were up 1 percent as well, with strength in R&D markets for WiMAX(TM) and LTE applications. Handset manufacturing test was down 2 percent from last year.
Fourth quarter income from operations of $133 million was down $4 million from last year on a $10 million increase in revenues. Gross margins were flat with last year while operating margins were off less than a point. Margins were hurt by a $12 million increase in currency-related costs as well as by increased acquisition-related spending. Aggressive asset management enabled segment ROIC(2) to remain stable at 27 percent despite lower segment income.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.4 billion in fiscal 2007. Information about Agilent is available on the Web at www.agilent.com.
Agilent's management will present more details on its fourth quarter FY2007 financial results on a conference call with investors beginning today at 1:30 p.m. (Pacific). This event will be webcast live in listen-only mode. Listeners may log on at www.investor.agilent.com and select "Q4 2007 Agilent Technologies Inc. Earnings Conference Call" in the "News & Events -- Calendar of Events" section. The webcast will remain available on the company's Web site for 90 days.
A telephone replay of the conference call will be available from 3:30 p.m. (Pacific) today through Nov. 22, 2007. The replay number is +1 888 286 8010 or international callers may dial +1 617 801 6888. The passcode is 76663083.
Forward-Looking Statements
This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding Agilent's future revenues, earnings and profitability; the pace of new product introductions and future demand for the Company's products and services; and guidance for the first quarter and for the full fiscal year 2008. These forward-looking statements involve risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of our customers' businesses, and unforeseen changes in the demand for current and new products and technologies.
In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles while it continues to implement cost reductions; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that our cost-cutting initiatives will impair our ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties on our operations, our markets and our ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; and other risks detailed in Agilent's filings with the Securities and Exchange Commission, including our Quarterly Report on Form 10-Q for the quarterly period ended July 31, 2007. Forward-looking statements are based on the beliefs and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.
(1) Adjusted net income and adjusted net income per share are non-GAAP measures. Each of these measures is defined to exclude primarily the impacts of restructuring and asset impairment charges, business separation costs, non-cash share-based compensation, intangible amortization as well as gains and losses from the sale of investments and disposals of businesses net of their tax effects. A reconciliation between adjusted net income and GAAP net income is set forth on page 5 of the attached tables along with additional information regarding the use of this non-GAAP measure.
(2) Return On Invested Capital is a non-GAAP measure and is defined as income (loss) from operations less other (income) expense and taxes, annualized, divided by the average of the two most recent quarter-end balances of assets less net current liabilities. The reconciliation of ROIC can be found on page 6 of the attached tables, along with additional information regarding the use of this non-GAAP measure.
(3) Adjusted net income per share as projected for Q108 and full year 2008 is a non-GAAP measure which excludes primarily the impacts of future restructuring and asset impairment charges, non-cash stock-based compensation, and intangibles amortization. Most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy. Therefore, no reconciliation to GAAP amounts has been provided. Future amortization of intangibles is expected to be approximately $13 million per quarter.
(4) Adjusted net income for Q107 of $0.39, adding $32 million of compensation expense, was $0.33 per share.
"WiMAX," "Fixed WiMAX," "Mobile WiMAX," "WiMAX Forum," the WiMAX Forum logo, "WiMAX Forum Certified," and the WiMAX Forum Certified logo are trademarks of the WiMAX Forum. All other trademarks are the properties of their respective owners.
NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available on the Agilent news site at www.agilent.com/go/news.
AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(In millions, except per share amounts)
(Unaudited)
PRELIMINARY
Three Months Ended
October 31,
------------------ Percent
2007 2006 Inc/(Dec)
--------- -------- ---------
Orders $ 1,483 $ 1,397 6%
Net revenue $ 1,446 $ 1,328 9%
Costs and expenses:
Cost of products and services 656 599 10%
Research and development 174 156 12%
Selling, general and administrative 426 424 -
--------- --------
Total costs and expenses 1,256 1,179 7%
--------- --------
Income from continuing operations 190 149 28%
Other income (expense), net 11 24 (54%)
--------- --------
Income from continuing operations before
taxes 201 173 16%
Provision for taxes 21 47 (55%)
--------- --------
Income from continuing operations, net 180 126 43%
Income from and gain on sale of
discontinued operations of our
Semiconductor Products Business (net of
taxes of ($2) million in 2006) - 1 (100%)
Income from the discontinued operations
of our Semiconductor Test Solutions
Business (net of taxes of $3 million in
2006) - 22 (100%)
--------- --------
Net income $ 180 $ 149 21%
========= ========
Net income per share - basic:
Income from continuing operations $ 0.48 $ 0.31
Income from and gain on sale of
discontinued operations of our
Semiconductor Products Business,
net - -
Income from the discontinued
operations of our Semiconductor
Test Solutions Business, net - 0.05
--------- --------
Net income per share - basic $ 0.48 $ 0.36
========= ========
Net income per share - diluted:
Income from continuing operations $ 0.46 $ 0.31
Income from and gain on sale of
discontinued operations of our
Semiconductor Products Business,
net - -
Income from the discontinued
operations of our Semiconductor
Test Solutions Business, net - 0.05
--------- --------
Net income per share - diluted $ 0.46 $ 0.36
========= ========
Weighted average shares used in computing
net income per share:
Basic 376 409
Diluted 388 418
Income from continuing operations for the fourth quarter of fiscal
years 2007 and 2006 include pre-tax share-based compensation expense
under SFAS No. 123(R) of $36 million and $21 million, respectively,
related to employee stock options and employee stock purchases.
The preliminary income statement is estimated based on our current
information.
Page 1
AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(In millions, except per share amounts)
(Unaudited)
PRELIMINARY
Twelve Months Ended
October 31,
------------------- Percent
2007 2006 Inc/(Dec)
--------- --------- ---------
Orders $ 5,441 $ 5,075 7%
Net revenue $ 5,420 $ 4,973 9%
Costs and expenses:
Cost of products and services 2,451 2,315 6%
Research and development 685 655 5%
Selling, general and administrative 1,700 1,660 2%
Gain on sale of San Jose and Palo Alto
sites - (121) 100%
--------- ---------
Total costs and expenses 4,836 4,509 7%
--------- ---------
Income from continuing operations 584 464 26%
Other income (expense), net 86 163 (47%)
--------- ---------
Income from continuing operations before
taxes and equity income 670 627 7%
Provision for taxes 32 91 (65%)
--------- ---------
Income from continuing operations before
equity income 638 536 19%
Equity income from and gain on sale of
Lumileds - 901 (100%)
--------- ---------
Income from continuing operations, net 638 1,437 (56%)
Income from and gain on sale of
discontinued operations of our
Semiconductor Products Business (net of
taxes of $8 million in 2006) - 1,816 (100%)
Income from the discontinued operations
of our Semiconductor Test Solutions
Business (net of taxes of $20 million
in 2006) - 54 (100%)
--------- ---------
Net income $ 638 $ 3,307 (81%)
========= =========
Net income per share - basic:
Income from continuing operations $ 1.62 $ 3.33
Income from and gain on sale of
discontinued operations of our
Semiconductor Products Business,
net - 4.21
Income from the discontinued
operations of our Semiconductor
Test Solutions Business, net - 0.13
--------- ---------
Net income per share - basic $ 1.62 $ 7.67
========= =========
Net income per share - diluted:
Income from continuing operations $ 1.57 $ 3.26
Income from and gain on sale of
discontinued operations of our
Semiconductor Products Business,
net - 4.12
Income from the discontinued
operations of our Semiconductor
Test Solutions Business, net - 0.12
--------- ---------
Net income per share - diluted $ 1.57 $ 7.50
========= =========
Weighted average shares used in
computing net income per share:
Basic 394 431
Diluted 406 441
Income from continuing operations for the fiscal years 2007 and 2006
include pre-tax share-based compensation expense under SFAS No.
123(R) of $139 million and $94 million, respectively, related to
employee stock options and employee stock purchases.
The preliminary income statement is estimated based on our current
information.
Page 2
AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEET
(In millions, except par value and share amounts)
(Unaudited)
PRELIMINARY
October 31, October 31,
2007 2006
----------- -----------
ASSETS
Current assets:
Cash and cash equivalents $ 1,826 $ 2,262
Accounts receivable, net 735 692
Inventory 643 627
Other current assets 464 377
----------- -----------
Total current assets 3,668 3,958
Property, plant and equipment, net 801 775
Goodwill and other intangible assets, net 736 468
Restricted cash and cash equivalents 1,615 1,606
Other assets 730 562
----------- -----------
Total assets $ 7,550 $ 7,369
=========== ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 323 $ 378
Employee compensation and benefits 432 414
Deferred revenue 249 225
Income and other taxes payable 541 390
Other accrued liabilities 135 131
----------- -----------
Total current liabilities 1,680 1,538
----------- -----------
Long-term debt 1,500 1,500
Senior notes 598 -
Retirement and post-retirement benefits 141 288
Other long-term liabilities 397 395
----------- -----------
Total liabilities 4,316 3,721
----------- -----------
Stockholders' equity:
Preferred stock; $0.01 par value; 125
million shares authorized; none issued and
outstanding - -
Common stock; $0.01 par value; 2 billion
shares authorized; 551 million shares at
October 31, 2007 and 535 million shares at
October 31, 2006 issued 6 5
Treasury stock at cost; 181 million shares
at October 31, 2007 and 127 million shares
at October 31, 2006 (6,469) (4,525)
Additional paid-in capital 7,117 6,605
Retained earnings 2,172 1,534
Accumulated other comprehensive income 408 29
----------- -----------
Total stockholders' equity 3,234 3,648
----------- -----------
Total liabilities and stockholders'
equity $ 7,550 $ 7,369
=========== ===========
The preliminary balance sheet is estimated based on our current
information.
Page 3
AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(In millions)
(Unaudited)
PRELIMINARY
Twelve Months Three Months
Ended Ended
October 31, October 31,
2007 2007
------------- ------------
Cash flows from operating activities:
Net income $ 638 $ 180
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation and amortization 191 48
Share-based compensation 139 36
Deferred taxes (153) (124)
Excess and obsolete inventory-related
charges 21 8
Asset impairment charges 8 -
Net gain on sale of investments (2) -
Net gain on sale of assets (13) -
In-process research and development and
others 1 -
Changes in assets and liabilities:
Accounts receivable 22 31
Inventory (21) 25
Accounts payable (13) 1
Employee compensation and benefits 13 63
Income taxes and other taxes payable 151 140
Other current assets and liabilities 29 6
Other long-term assets and liabilities (42) (16)
------------- ------------
Net cash provided by operating activities
(a) 969 398
Cash flows from investing activities:
Investments in property, plant and
equipment (154) (39)
Proceeds from the sale of property, plant
and equipment 12 -
Proceeds from sale of investments 13 1
Proceeds from sale of intangibles and
assets, net 14 -
Change in restricted cash and cash
equivalents, net 3 2
Acquisition of businesses and intangible
assets, net of cash acquired (344) (33)
------------- ------------
Net cash used in investing activities (456) (69)
Cash flows from financing activities:
Net issuance of common stock under
employee stock plans 375 31
Treasury stock repurchases (1,944) (631)
Issuance of senior notes 598 598
Senior notes issuance costs (5) (5)
Payment of long-term debt (4) -
------------- ------------
Net cash used in financing activities (980) (7)
Effect of exchange rate movements 31 18
Net increase (decrease) in cash and cash
equivalents (436) 340
Cash and cash equivalents at beginning of
period 2,262 1,486
------------- ------------
Cash and cash equivalents at end of period $ 1,826 $ 1,826
============= ============
(a) Cash payments included in operating
activities:
Restructuring 70 16
Income tax payments 79 16
The preliminary cash flow statement is estimated based on our current
information.
Page 4
AGILENT TECHNOLOGIES, INC.
ADJUSTED NET INCOME AND DILUTED EPS RECONCILIATIONS
(In millions, except per share amounts)
(Unaudited)
PRELIMINARY
Three Months Ended
October 31,
Diluted Diluted
2007 EPS 2006 EPS
------ -------- ------ -------
Net income per GAAP $ 180 $ 0.46 $ 149 $ 0.36
Less income from and gain on sale of
discontinued operations of our
Semiconductor Products Business - - 1 -
Less income from discontinued
operations of our Semiconductor Test
Solutions Business - - 22 0.05
------ -------- ------ -------
Income from continuing operations $ 180 $ 0.46 $ 126 $ 0.31
Non-GAAP adjustments:
Restructuring and asset impairment 9 0.02 39 0.09
Business disposal and
infrastructure reduction costs - - 8 0.02
Gain on sale of assets - - - -
Share-based compensation expense 36 0.09 21 0.05
Excess software amortization 4 0.01 5 0.01
Intangible amortization 11 0.03 9 0.02
Donation to Agilent Foundation - - - -
Remeasurement loss for a one-time
intercompany transaction - - - -
Gain on sale and equity in income
of Lumileds - - - -
Income from Foreign Sales
Corporation Tax Study - - (2) -
Retirement Plans Curtailment Gains - - (5) (0.01)
Unallocated SPG corporate charges,
net - - 1 -
Unallocated STS corporate charges,
net - - 19 0.04
Other 3 0.01 (10) (0.03)
Adjustment for taxes (37) (0.09) (21) (0.05)
------ -------- ------ -------
Adjusted net income from continuing
operations $ 206 $ 0.53 $ 190 $ 0.45
====== ======== ====== =======
Add net income for discontinued
segments (non-GAAP) - 25
------ -------- ------ -------
Adjusted net income $ 206 $ 0.53 $ 215 $ 0.51
====== ======== ====== =======
Twelve Months Ended
October 31,
Diluted Diluted
2007 EPS 2006 EPS
------ ------- ------- -------
Net income per GAAP $ 638 $ 1.57 $3,307 $ 7.50
Less income from and gain on sale of
discontinued operations of our
Semiconductor Products Business - - 1,816 4.12
Less income from discontinued
operations of our Semiconductor Test
Solutions Business - - 54 0.12
------ ------- ------- -------
Income from continuing operations $ 638 $ 1.57 $1,437 $ 3.26
Non-GAAP adjustments:
Restructuring and asset impairment 39 0.10 170 0.39
Business disposal and
infrastructure reduction costs 14 0.03 63 0.14
Gain on sale of assets (15) (0.04) (121) (0.28)
Share-based compensation expense 139 0.34 94 0.21
Excess software amortization 26 0.07 5 0.01
Intangible amortization 40 0.10 28 0.06
Donation to Agilent Foundation 20 0.05 - -
Remeasurement loss for a one-time
intercompany transaction 4 0.01 - -
Gain on sale and equity in income
of Lumileds - - (901) (2.04)
Income from Foreign Sales
Corporation Tax Study - - (15) (0.03)
Retirement Plans Curtailment Gains - - (23) (0.05)
Unallocated SPG corporate charges,
net - - 14 0.03
Unallocated STS corporate charges,
net - - 59 0.13
Other 10 0.02 (19) (0.03)
Adjustment for taxes (177) (0.43) (136) (0.31)
------ ------- ------- -------
Adjusted net income from continuing
operations $ 738 $ 1.82 $ 655 $ 1.49
====== ======= ======= =======
Add net income for discontinued
segments (non-GAAP) - 89
------ ------- ------- -------
Adjusted net income $ 738 $ 1.82 $ 744 $ 1.69
====== ======= ======= =======
We provide adjusted net income and adjusted net income per share
amounts in order to provide meaningful supplemental information
regarding our operational performance and our prospects for the
future. These supplemental measures exclude, among other things,
expenses related to share-based compensation, charges related to the
amortization of intangibles, the impact of restructuring charges and
the sale of our businesses. Some of the exclusions, such as
impairments, may be beyond the control of management. Further, some
may be less predictable than revenue derived from our core businesses
(the day to day business of selling our products and services). These
reasons provide the basis for management's belief that the measures
are useful.
Our management uses non-GAAP measures to evaluate the performance of
our core businesses, to estimate future core performance and to
compensate employees. Since management finds this measure to be
useful, we believe that our investors benefit from seeing our results
"through the eyes" of management in addition to seeing our GAAP
results. This information facilitates our management's internal
comparisons to our historical operating results as well as to the
operating results of our competitors.
Our management recognizes that items such as share-based compensation
expenses, amortization of intangibles and restructuring charges can
have a material impact on our cash flows and/or our net income. Our
GAAP financial statements including our statement of cash flows
portray those effects. Although we believe it is useful for investors
to see core performance free of special items, investors should
understand that the excluded items are actual expenses that may
impact the cash available to us for other uses. To gain a complete
picture of all effects on the Company's profit and loss from any and
all events, management does (and investors should) rely upon the GAAP
income statement. The non-GAAP numbers focus instead upon the core
business of the company, which is only a subset, albeit a critical
one, of the Company's performance.
Readers are reminded that non-GAAP numbers are merely a supplement to,
and not a replacement for, GAAP financial measures. They should be
read in conjunction with the GAAP financial measures. It should be
noted as well that our non-GAAP information may be different from the
non-GAAP information provided by other companies.
The preliminary adjusted net income and diluted EPS reconciliation is
estimated based on our current information.
Page 5
AGILENT TECHNOLOGIES, INC.
RECONCILIATION OF ROIC
(In millions)
(Unaudited)
Preliminary
BAM EM Agilent
Numerator: Q4'07 Q4'07 Q4'07
--------- -------- ---------
Adjusted income from operations $ 120 $ 133 $ 253
Less:
Taxes and Other (income)/expense 34 29 60
--------- -------- ---------
Segment return 86 104 193 (a)
--------- -------- ---------
Segment return annualized $ 344 $ 416 $ 772
========= ======== =========
Denominator:
Segment assets (b) $ 1,307 $ 2,025 $ 3,341
Less:
Net current liabilities (c) 252 502 755
--------- -------- ---------
Invested capital $ 1,055 $ 1,523 $ 2,586
--------- -------- ---------
Average invested capital $ 1,052 $ 1,551 $ 2,615
ROIC 33% 27% 30%
BAM EM BAM EM
Numerator: Q4'06 Q4'06 Q3'07 Q3'07
------- ------- ------- -------
Adjusted income from operations $ 91 $ 137 $ 92 $ 133
Less:
Taxes and Other (income)/expense 26 31 25 28
------- ------- ------- -------
Segment return 65 106 67 105
------- ------- ------- -------
Segment return annualized $ 260 $ 424 $ 268 $ 420
======= ======= ======= =======
Denominator:
Segment assets (b) $1,003 $2,075 $1,304 $2,042
Less:
Net current liabilities (c) 272 553 254 463
------- ------- ------- -------
Invested capital $ 731 $1,522 $1,050 $1,579
------- ------- ------- -------
Average invested capital $ 732 $1,548 $ 932 $1,590
ROIC 36% 27% 29% 26%
ROIC calculation:(annualized current quarter segment return)/(average
of the two most recent quarter-end balances of Segment Invested
Capital)
(a) Agilent return is equal to adjusted net income from continuing
operations of $206 million minus net interest income after tax of $13
million.
Please see "Adjusted Net Income and EPS Reconciliations" for a
reconciliation of adjusted net income from continuing operations
to GAAP income from continuing operations.
(b) Segment assets consist of inventory, accounts receivable, property
plant and equipment, gross goodwill and other intangibles, deferred
taxes and allocated corporate assets.
(c) Includes accounts payable, employee compensation and benefits,
other accrued liabilities and allocated corporate liabilities.
Return on invested capital (ROIC) is a non-GAAP measure that
management believes provides useful supplemental information for
management and the investor. ROIC is a tool by which we track how
much value we are creating for our shareholders. Management uses ROIC
as a performance measure for our businesses, and our senior managers'
compensation is linked to ROIC improvements as well as other
performance criteria. We believe that ROIC provides our management
with a means to analyze and improve their business, measuring segment
profitability in relation to net asset investments. We acknowledge
that ROIC may not be calculated the same way by every company. We
compensate for this limitation by monitoring and providing to the
reader a full GAAP income statement and balance sheet.
Readers are reminded that non-GAAP numbers are merely a supplement to,
and not a replacement for, GAAP financial measures. They should be
read in conjunction with the GAAP financial measures. It should be
noted as well that our non-GAAP information may be different from the
non-GAAP information provided by other companies.
The preliminary reconciliation of ROIC is estimated based on our
current information.
Page 6
Contact:
Agilent Technologies Inc.
Amy Flores, +1-408-345-8194 (Editorial)
Email Contact
Jorgen
Tesselaar, +31 20 547 2825 (Editorial)
(Europe and Asia)
Email Contact
Rodney
Gonsalves, +1-408-345-8948 (Investor)
Email Contact